Faculty profile

Laura Hopkins

Back to faculty

ProfessorDivision of Oncology & Department of GynecologyUniversity of Saskatchewan

Laura Hopkins

Professor

Division of Oncology & Department of Gynecology

College of Medicine

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
25 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

110

Publications

1,980

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Saskatchewan profile.

Latest papers

Oncofertility Needs Assessment of Adolescent/Young Adult Cancer Survivors in Saskatchewan, Canada
Journal of Adolescent and Young Adult Oncology · 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.
Current oncology (Toronto, Ont.) · 2026
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Signal transduction and targeted therapy · 2026

All 110 publications

110 publications.

Oncofertility Needs Assessment of Adolescent/Young Adult Cancer Survivors in Saskatchewan, Canada

Sierra K. Leonard, Huyen T. Vu, Saima Alvi, Elke E. Mau, T Domes, Laura Hopkins, P D’Alessandro

Journal of Adolescent and Young Adult Oncology2026

DOI: 10.1177/21565333261464960 PMID: 42359745

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Ma K, Tessier-Cloutier B, Altman AD, Carey MS, Ethier JL, Lau S, Lee CH, Hopkins L, Kieser K, Kumar A, Leung SOA, Nguyen JMV, MacKay H, McGee J, Salman L, Salvador S, Sluce C, Tatar L, Tone AA, Tinker A, Tremblay E, Veneziani AC, Vicus D, Welch S, Windsor Harker S, Brodeur MN

Current oncology (Toronto, Ont.)2026Open Access

DOI: 10.3390/curroncol33060330 PMID: 42346230

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Price JDW, Vizeacoumar FS, Abuhussein O, Maranda V, Zhang Y, Adachi H, Nguyen K, Kyrylenko L, Rangel-Pozzo A, Dong H, Gong L, Materi A, Walke P, Ganapathysamy A, Denomy C, Freywald T, Dahiya R, Elhasasna H, Saxena A, Vizeacoumar JP, Patel H, Rajamanickam K, de Oliveira DM, Lazell-Wright M, Morales AM, Aggarwal A, Xu JL, Alli N, Munhoz EP, Gao P, Salsman J, Dahiya DK, Kola NS, Gonzalez-Lopez C, Thibault P, Levin M, Dellaire G, Jette N, Groot G, Köbel M, Lee CH, Hopkins L, Krishnan A, Ahmed S, Eskiw C, Barakat KH, Thakur A, Wu Y, DePinho RA, Mai S, Yu YT, Wong JMY, Freywald A, Vizeacoumar FJ

Signal transduction and targeted therapy2026Open Access

DOI: 10.1038/s41392-026-02750-0 PMID: 42236690

Applying the health belief model to explore healthcare provider and patient perspectives on homologous recombination deficiency testing in cancer: A narrative review

Kim DK, Mostafa M, Aizenberg Y, Brodeur MN, Carey MS, Ferguson SE, Hopkins L, Kong I, Kwon JS, Lau S

Cancer Treatment and Research Communications2026Open Access

DOI: 10.1016/j.ctarc.2026.101238

The real-world utility of homologous repair deficiency testing in BRCA1/2 wild-type high-grade serous carcinoma and the utility of MYC amplification as a potential surrogate marker

Radha Maradiya, Mary Kinloch, Antonio De Leo, Dario de Biase, Soufian El Hallani, Giovanni Tallini, Laura Hopkins, Mark S. Carey, Martin Köbel, Cheng-Han Lee, Christa Aubrey

Gynecologic Oncology2026Open Access

DOI: 10.1016/j.ygyno.2026.06.011 PMID: 42442041

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

Cunningham CE, Vizeacoumar FS, Zhang Y, Kyrylenko L, Both S, Maranda V, Dong H, Price JDW, Gao P, Wagner K, Wu Y, Lazell-Wright M, Ganapathysamy A, Hari R, Bhanumathy KK, Denomy C, Saxena A, Vizeacoumar JP, Morales AM, Khan F, Mosley S, Chen A, Katrii T, Zoller BGE, Rajamanickam K, Walke P, Gong L, Patel H, Elhasasna H, Dahiya R, Abuhussein O, Dmitriev A, Freywald T, Munhoz EP, Ruppin E, Lee JS, Rox K, Koebel M, Hopkins L, Lee CH, Yadav S, Gasparoni G, Walter J, Krishnan A, Datla R, Toosi B, Baker K, Meens J, Cescon DW, Ailles L, Leary SC, Wu Y, Empting M, Kiemer AK, Freywald A, Vizeacoumar FJ

Cell genomics20256 citationsOpen Access

DOI: 10.1016/j.xgen.2025.100876 PMID: 40347943

Organoid Pharmacotyping of Pancreatic Cancer Enables Functional Precision Oncology and Drug Repurposing

He Dong, Frederick S. Vizeacoumar, Frederick S. Vizeacoumar, Yue Zhang, Nicholas Jette, Jared D. W. Price, Vincent Maranda, Lihui Gong, Tanya Freywald, Jeff Patrick Vizeacoumar, Mary Lazell-Wright, Saruul Uuganbayar, Jaylynn Quail, Alain Morejon Morales, Ayaan Rizvi, Rani Kanthan, Yuliang Wu, Anand Krishnan, Kathleen E. A. Felton, Bilal M. Marwa, Laura Hopkins, Gary Groot, John M. Shaw, Gavin Beck, Yigang Luo, Maurice Ogaick, Mike Moser, Andrew Freywald, Shahid Ahmed, Adnan Zaidi, et al. (32 authors)

bioRxiv (Cold Spring Harbor Laboratory)20253 citations

DOI: 10.64898/2025.12.01.691211

Putting Patients First: Pragmatic Trials in Gynecologic Oncology.

Hopkins L, Clemons M, Bemister K, Booth C, Kadar S, Karanicolas P, Mulligan J, Savard MF, Tannock I, Tone A, MacKay H

Current oncology (Toronto, Ont.)20251 citationsFirst authorOpen Access

DOI: 10.3390/curroncol32030139 PMID: 40136343

Hospital learning curves for robot-assisted surgeries: a population-based analysis

Walker RJB, Stukel TA, de Mestral C, Nathens A, Breau RH, Hanna WC, Hopkins L, Schlachta CM, Jackson TD, Shayegan B

Surgical Endoscopy202413 citations

DOI: 10.1007/s00464-023-10625-6

Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes.

Dhillon G, Llaurado-Fernandez M, Tessier-Cloutier B, Sy K, Bassiouny D, Han G, Wong NKY, McRae K, Kinloch M, Pors J, Hopkins L, Covens A, Köbel M, Lee CH, Carey MS

Frontiers in oncology20244 citationsOpen Access

DOI: 10.3389/fonc.2024.1408196 PMID: 39220645

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Laura Hopkins

Research

Latest papers

Oncofertility Needs Assessment of Adolescent/Young Adult Cancer Survivors in Saskatchewan, Canada

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Applying the health belief model to explore healthcare provider and patient perspectives on homologous recombination deficiency testing in cancer: A narrative review

The real-world utility of homologous repair deficiency testing in BRCA1/2 wild-type high-grade serous carcinoma and the utility of MYC amplification as a potential surrogate marker

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

Organoid Pharmacotyping of Pancreatic Cancer Enables Functional Precision Oncology and Drug Repurposing

Putting Patients First: Pragmatic Trials in Gynecologic Oncology.

Hospital learning curves for robot-assisted surgeries: a population-based analysis

Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes.

Frequent collaborators

Tien Le

Michael Fung-Kee-Fung

Sukhbir Singh

Wylam Faught

Andrew Freywald

Cheng-Han Lee

Martin Koebel

Olga Bougie

Wendy Wolfman

Wael Hanna

Stephen Pautler

Innie Chen

Nicholas Leyland

Avery Nathens

Marc Gaudet

Mark Carey

Rodney Breau

Christopher Schlachta

Yuliang Wu

Bobby Shayegan

Mary Kinloch

Raju Datla

Laura Hopkins

Research

Latest papers

Oncofertility Needs Assessment of Adolescent/Young Adult Cancer Survivors in Saskatchewan, Canada

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor &#x3b1; Testing in Ovarian Cancer.

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Applying the health belief model to explore healthcare provider and patient perspectives on homologous recombination deficiency testing in cancer: A narrative review

The real-world utility of homologous repair deficiency testing in BRCA1/2 wild-type high-grade serous carcinoma and the utility of MYC amplification as a potential surrogate marker

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

Organoid Pharmacotyping of Pancreatic Cancer Enables Functional Precision Oncology and Drug Repurposing

Putting Patients First: Pragmatic Trials in Gynecologic Oncology.

Hospital learning curves for robot-assisted surgeries: a population-based analysis

Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes.

Frequent collaborators

Tien Le

Michael Fung-Kee-Fung

Sukhbir Singh

Wylam Faught

Andrew Freywald

Cheng-Han Lee

Martin Koebel

Olga Bougie

Wendy Wolfman

Wael Hanna

Stephen Pautler

Innie Chen

Nicholas Leyland

Avery Nathens

Marc Gaudet

Mark Carey

Rodney Breau

Christopher Schlachta

Yuliang Wu

Bobby Shayegan

Mary Kinloch

Raju Datla

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.